Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients

(UT Southwestern Medical Center) A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients.